10x Genomics, Inc.
MX ˙ BMV ˙ US88025U1097
SecurityMX:TXG / 10x Genomics, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership743,734 shares
Latest Disclosed Value $ 15,789,473
Citadel Advisors Llc ownership in TXG / 10x Genomics, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 743,734 shares of 10x Genomics, Inc. (MX:TXG) valued at $15,789,473 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 130,820 shares of 10x Genomics, Inc.. This represents a change in shares of 468.52% during the quarter.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (TXG) in the form of stock options. The firm currently holds call options representing 174,700 of underlying shares valued at $3,708,881 USD and put options representing 13,300 of underlying shares valued at $282,359 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:TXG / 10x Genomics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F 10X GENOMICS CL A COM 88025U109 743,734 612,914 468.52 15,789 640.23 0.0022
2026-02-17 2025-12-31 13F 10X GENOMICS CL A COM 88025U109 130,820 130,820 2,134 0.0003
2025-11-14 2025-09-30 13F 10X GENOMICS CL A COM 88025U109 0 -195,944 -100.00 0 -100.00
2025-08-14 2025-06-30 13F 10X GENOMICS CL A COM 88025U109 195,944 -868,322 -81.59 2,269 -75.58 0.0004
2025-05-15 2025-03-31 13F 10X GENOMICS CL A COM 88025U109 1,064,266 -942,092 -46.96 9,291 -67.75 0.0018
2025-02-14 2024-12-31 13F 10X GENOMICS CL A COM 88025U109 2,006,358 -773,612 -27.83 28,811 -54.10 0.0050
2024-11-14 2024-09-30 13F 10X GENOMICS CL A COM 88025U109 2,779,970 2,445,577 731.35 62,772 865.26 0.0121
2024-08-14 2024-06-30 13F 10X GENOMICS CL A COM 88025U109 334,393 247,234 283.66 6,504 98.81 0.0013
2024-05-15 2024-03-31 13F 10X GENOMICS CL A COM 88025U109 87,159 -27,066 -23.70 3,271 -48.83 0.0006
2024-02-14 2023-12-31 13F 10X GENOMICS CL A COM 88025U109 114,225 98,920 646.32 6,392 913.00 0.0013
2023-11-14 2023-09-30 13F 10X GENOMICS CL A COM 88025U109 15,305 -706,265 -97.88 631 -98.43 0.0001
2023-08-14 2023-06-30 13F 10X GENOMICS CL A COM 88025U109 721,570 -508,557 -41.34 40,292 -41.29 0.0083
2023-05-15 2023-03-31 13F 10X GENOMICS CL A COM 88025U109 1,230,127 -233,774 -15.97 68,629 28.65 0.0151
2023-02-14 2022-12-31 13F 10X GENOMICS CL A COM 88025U109 1,463,901 1,108,820 312.27 53,345 427.48 0.0125
2022-11-14 2022-09-30 13F 10X GENOMICS CL A COM 88025U109 355,081 222,348 167.52 10,113 68.35 0.0023
2022-08-15 2022-06-30 13F 10X GENOMICS CL A COM 88025U109 132,733 132,733 6,007 0.0015
2022-05-16 2022-03-31 13F 10X GENOMICS CL A COM 88025U109 0 -5,616 -100.00 0 -100.00
2022-02-14 2021-12-31 13F 10X GENOMICS CL A COM 88025U109 5,616 -59,506 -91.38 837 -91.17 0.0002
2021-11-15 2021-09-30 13F 10X GENOMICS Cmn 88025U109 65,122 -10,108 -13.44 9,480 -35.65 0.0020
2021-08-16 2021-06-30 13F 10X GENOMICS CL A COM 88025U109 75,230 72,604 2,764.81 14,732 3,001.47 0.0033
2021-05-21 2021-03-31 13F/A-1 10X GENOMICS CL A COM 88025U109 2,626 -203,255 -98.72 475 -98.37 0.0001
2021-05-17 2021-03-31 13F 10X GENOMICS CL A COM 88025U109 2,626 -203,255 475 0.0001
2021-02-16 2020-12-31 13F 10X GENOMICS CL A COM 88025U109 205,881 89,316 76.62 29,153 100.60 0.0076
2020-11-16 2020-09-30 13F 10X GENOMICS CL A COM 88025U109 116,565 114,008 4,458.66 14,533 6,274.12 0.0041
2020-08-14 2020-06-30 13F 10X GENOMICS Cmn 88025U109 2,557 -25,504 -90.89 228 -86.96 0.0001
2020-05-15 2020-03-31 13F 10X GENOMICS Cmn 88025U109 28,061 4,443 18.81 1,749 -2.89 0.0008
2020-02-14 2019-12-31 13F 10X GENOMICS Cmn 88025U109 23,618 -81,852 -77.61 1,801 -66.12 0.0008
2019-11-14 2019-09-30 13F 10X GENOMICS Cmn 88025U109 105,470 105,470 5,316 0.0025
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F 10X GENOMICS CL A COM Call 174,700 63.12 3,709 112.37 n/a n/a n/a
2026-02-17 2025-12-31 13F 10X GENOMICS CL A COM Call 107,100 62.77 1,747 127.05 n/a n/a n/a
2025-11-14 2025-09-30 13F 10X GENOMICS CL A COM Call 65,800 -55.24 769 -54.82 n/a n/a n/a
2025-08-14 2025-06-30 13F 10X GENOMICS CL A COM Call 147,000 2.65 1,702 36.16 n/a n/a n/a
2025-05-15 2025-03-31 13F 10X GENOMICS CL A COM Call 143,200 250.12 1,250 112.95 n/a n/a n/a
2025-02-14 2024-12-31 13F 10X GENOMICS CL A COM Call 40,900 -37.56 587 -60.28 n/a n/a n/a
2024-11-14 2024-09-30 13F 10X GENOMICS CL A COM Call 65,500 150.00 1,479 190.37 n/a n/a n/a
2024-08-14 2024-06-30 13F 10X GENOMICS CL A COM Call 26,200 -75.81 510 -87.48 n/a n/a n/a
2024-05-15 2024-03-31 13F 10X GENOMICS CL A COM Call 108,300 5.04 4,064 -29.55 n/a n/a n/a
2024-02-14 2023-12-31 13F 10X GENOMICS CL A COM Call 103,100 -27.60 5,769 -1.79 n/a n/a n/a
2023-11-14 2023-09-30 13F 10X GENOMICS CL A COM Call 142,400 39.33 5,874 2.94 n/a n/a n/a
2023-08-14 2023-06-30 13F 10X GENOMICS CL A COM Call 102,200 44.55 5,707 44.68 n/a n/a n/a
2023-05-15 2023-03-31 13F 10X GENOMICS CL A COM Call 70,700 260.71 3,944 452.38 n/a n/a n/a
2023-02-14 2022-12-31 13F 10X GENOMICS CL A COM Call 19,600 -71.51 714 -63.55 n/a n/a n/a
2022-11-14 2022-09-30 13F 10X GENOMICS CL A COM Call 68,800 119.81 1,959 38.35 n/a n/a n/a
2022-08-15 2022-06-30 13F 10X GENOMICS CL A COM Call 31,300 -53.00 1,416 -72.05 n/a n/a n/a
2022-05-16 2022-03-31 13F 10X GENOMICS CL A COM Call 66,600 -5.67 5,066 -51.83 n/a n/a n/a
2022-02-14 2021-12-31 13F 10X GENOMICS CL A COM Call 70,600 77.83 10,517 81.96 n/a n/a n/a
2021-11-15 2021-09-30 13F 10X GENOMICS Cmn Call 39,700 24.45 5,780 -7.48 n/a n/a n/a
2021-08-16 2021-06-30 13F 10X GENOMICS CL A COM Call 31,900 17.28 6,247 26.89 n/a n/a n/a
2021-05-21 2021-03-31 13F/A 10X GENOMICS CL A COM Call 27,200 -15.79 4,923 7.63 n/a n/a n/a
2021-05-17 2021-03-31 13F 10X GENOMICS CL A COM Call 27,200 4,923 n/a n/a n/a
2021-02-16 2020-12-31 13F 10X GENOMICS CL A COM Call 32,300 -1.22 4,574 12.19 n/a n/a n/a
2020-11-16 2020-09-30 13F 10X GENOMICS CL A COM Call 32,700 35.12 4,077 88.66 n/a n/a n/a
2020-08-14 2020-06-30 13F 10X GENOMICS Cmn Call 24,200 -20.66 2,161 13.68 n/a n/a n/a
2020-05-15 2020-03-31 13F 10X GENOMICS Cmn Call 30,500 104.70 1,901 67.34 n/a n/a n/a
2020-02-14 2019-12-31 13F 10X GENOMICS Cmn Call 14,900 1,136 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F 10X GENOMICS CL A COM Put 13,300 26.67 282 64.91 n/a n/a n/a
2026-02-17 2025-12-31 13F 10X GENOMICS CL A COM Put 10,500 -76.14 171 -66.73 n/a n/a n/a
2025-11-14 2025-09-30 13F 10X GENOMICS CL A COM Put 44,000 1.62 514 2.59 n/a n/a n/a
2025-08-14 2025-06-30 13F 10X GENOMICS CL A COM Put 43,300 -13.23 501 15.17 n/a n/a n/a
2025-05-15 2025-03-31 13F 10X GENOMICS CL A COM Put 49,900 12.39 436 -31.71 n/a n/a n/a
2025-02-14 2024-12-31 13F 10X GENOMICS CL A COM Put 44,400 57.45 638 0.16 n/a n/a n/a
2024-11-14 2024-09-30 13F 10X GENOMICS CL A COM Put 28,200 52.43 637 77.16 n/a n/a n/a
2024-08-14 2024-06-30 13F 10X GENOMICS CL A COM Put 18,500 86.87 360 -3.23 n/a n/a n/a
2024-05-15 2024-03-31 13F 10X GENOMICS CL A COM Put 9,900 -70.62 372 -80.32 n/a n/a n/a
2024-02-14 2023-12-31 13F 10X GENOMICS CL A COM Put 33,700 -26.42 1,886 -0.21 n/a n/a n/a
2023-11-14 2023-09-30 13F 10X GENOMICS CL A COM Put 45,800 54.73 1,889 14.35 n/a n/a n/a
2023-08-14 2023-06-30 13F 10X GENOMICS CL A COM Put 29,600 -58.49 1,653 -58.46 n/a n/a n/a
2023-05-15 2023-03-31 13F 10X GENOMICS CL A COM Put 71,300 241.15 3,978 422.60 n/a n/a n/a
2023-02-14 2022-12-31 13F 10X GENOMICS CL A COM Put 20,900 -15.04 762 8.56 n/a n/a n/a
2022-11-14 2022-09-30 13F 10X GENOMICS CL A COM Put 24,600 -60.77 701 -75.29 n/a n/a n/a
2022-08-15 2022-06-30 13F 10X GENOMICS CL A COM Put 62,700 143.02 2,837 44.52 n/a n/a n/a
2022-05-16 2022-03-31 13F 10X GENOMICS CL A COM Put 25,800 104.76 1,963 4.58 n/a n/a n/a
2022-02-14 2021-12-31 13F 10X GENOMICS CL A COM Put 12,600 -87.86 1,877 -87.58 n/a n/a n/a
2021-11-15 2021-09-30 13F 10X GENOMICS Cmn Put 103,800 927.72 15,111 663.95 n/a n/a n/a
2021-08-16 2021-06-30 13F 10X GENOMICS CL A COM Put 10,100 -16.53 1,978 -9.68 n/a n/a n/a
2021-05-21 2021-03-31 13F/A 10X GENOMICS CL A COM Put 12,100 -21.94 2,190 -0.23 n/a n/a n/a
2021-05-17 2021-03-31 13F 10X GENOMICS CL A COM Put 12,100 2,190 n/a n/a n/a
2021-02-16 2020-12-31 13F 10X GENOMICS CL A COM Put 15,500 -25.84 2,195 -15.77 n/a n/a n/a
2020-11-16 2020-09-30 13F 10X GENOMICS CL A COM Put 20,900 51.45 2,606 111.53 n/a n/a n/a
2020-08-14 2020-06-30 13F 10X GENOMICS Cmn Put 13,800 14.05 1,232 63.40 n/a n/a n/a
2020-05-15 2020-03-31 13F 10X GENOMICS Cmn Put 12,100 7.08 754 -12.53 n/a n/a n/a
2020-02-14 2019-12-31 13F 10X GENOMICS Cmn Put 11,300 862 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.